Iradimed Corp (IRMD)
NASDAQ:IRMD
Want to see IRMD full AI Analyst Report?
Total Valuation
Iradimed has a market cap or net worth of $1.07B. The enterprise value is $1.02B.
Market Cap$1.07B
Enterprise Value$1.02B
Share Statistics
Iradimed has 12,782,566 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,782,566
Owned by Insiders35.18%
Owned by Institutions1.45%
Financial Efficiency
Iradimed’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 21.02%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.21
Return on Invested Capital (ROIC)21.02%
Return on Capital Employed (ROCE)0.27
Revenue Per Employee523.84K
Profits Per Employee140.50K
Employee Count160
Asset Turnover0.77
Inventory Turnover1.68
Valuation Ratios
The current PE Ratio of Iradimed is 55.1. Iradimed’s PEG ratio is 3.35.
PE Ratio55.1
PS Ratio14.77
PB Ratio13.08
Price to Fair Value13.08
Price to FCF72.03
Price to Operating Cash Flow42.60
PEG Ratio3.35
Income Statement
In the last 12 months, Iradimed had revenue of 83.81M and earned 22.48M in profits. Earnings per share was 1.77.
Revenue83.81M
Gross Profit64.32M
Operating Income26.15M
Pretax Income28.36M
Net Income22.48M
EBITDA28.53M
Earnings Per Share (EPS)1.77
Cash Flow
In the last 12 months, operating cash flow was 24.95M and capital expenditures -8.14M, giving a free cash flow of 16.81M billion.
Operating Cash Flow24.95M
Free Cash Flow16.81M
Free Cash Flow per Share1.31
Dividends & Yields
Iradimed pays an annual dividend of $0.5, resulting in a dividend yield of 1.22%
Dividend Per Share$0.5
Dividend Yield1.22%
Payout Ratio64.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change59.94%
50-Day Moving Average98.86
200-Day Moving Average84.20
Relative Strength Index (RSI)42.38
Average Volume (3m)86.64K
Important Dates
Iradimed upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).
Last Earnings DateMay 1, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Iradimed as a current ratio of 7.98, with Debt / Equity ratio of 0.00%
Current Ratio7.98
Quick Ratio6.84
Debt to Market Cap0.00
Net Debt to EBITDA-1.79
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Iradimed has paid 5.88M in taxes.
Income Tax5.88M
Effective Tax Rate0.21
Enterprise Valuation
Iradimed EV to EBITDA ratio is 41.59, with an EV/FCF ratio of 69.05.
EV to Sales14.16
EV to EBITDA41.59
EV to Free Cash Flow69.05
EV to Operating Cash Flow47.56
Balance Sheet
Iradimed has $51.16M in cash and marketable securities with $0.00 in debt, giving a net cash position of $51.16M billion.
Cash & Marketable Securities$51.16M
Total Debt$0.00
Net Cash$51.16M
Net Cash Per Share$4.00
Tangible Book Value Per Share$7.17
Margins
Gross margin is 76.75%, with operating margin of 31.20%, and net profit margin of 26.82%.
Gross Margin76.75%
Operating Margin31.20%
Pretax Margin33.84%
Net Profit Margin26.82%
EBITDA Margin34.04%
EBIT Margin31.20%
Analyst Forecast
The average price target for Iradimed is $118.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$118.67
Price Target Upside55.28% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast14.43%
EPS Growth Forecast16.40%